Perkins, K A <br/><br/>
Cross-validation of a new procedure for early screening of smoking cessation medications in humans.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jul 2010 
 - 109-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Validation Study 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2010.65  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Benzazepines--adverse effects<br/>Cross-Over Studies<br/>Data Interpretation, Statistical<br/>Double-Blind Method<br/>Drug Evaluation, Preclinical<br/>Female<br/>Humans<br/>Male<br/>Motivation<br/>Nicotine--administration & dosage<br/>Nicotinic Agonists--administration & dosage<br/>Quinoxalines--adverse effects<br/>Reproducibility of Results<br/>Research Design<br/>Smoking--psychology<br/>Smoking Cessation--methods<br/>Surveys and Questionnaires<br/>Varenicline